Prevalence of Familial Hypercholesterolemia in Pakistan: A Pooled Analysis of 1.5 Million Individuals and Comparison with Other Countries of the Region
Global Heart · 2025
DOI: 10.5334/gh.1413 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Global Heart, 2025. Verfasst von Madeeha Khan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Atta ur Rehman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan. Hauptthemen laut MEDLINE: Hyperlipoproteinemia Type II. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Familial hypercholesterolemia (FH) is an inherited disorder that causes elevated LDL-C levels leading to premature cardiovascular disease but remains underdiagnosed. This study aims to determine the prevalence of FH in Pakistan using data from multiple laboratory networks and compare it with other counties of the region.
Methods
The study analyzed lipid profile data from two large laboratory networks in Pakistan, applying Make Early Diagnosis to Prevent Early Death (MEDPED) LDL-C criteria for the general population to identify FH cases. A pooled prevalence estimate of prevalence of FH in Pakistan was calculated by combining the data of studies reporting prevalence in Pakistan. A systematic review was conducted to assess FH prevalence in South and Southeast Asian countries.
Results
Analysis of 545,087 individuals (Median age 45 years, 58.2% males) identified 2,911 FH cases [0.55%, 95% confidence interval (CI): 0.53–0.57%), equivalent to a prevalence of 1:182. Pooled analysis with a previous Pakistani study, totaling 1,533,393 subjects, estimated the overall FH prevalence in Pakistan at 1:273 (95% CI: 0.21–0.64%). Prevalence decreased with age, being highest in the
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Atta ur Rehman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan.
- Shifa Tameer-e-Millat University, Islamabad, Pakistan.
- Translational Genomics Laboratory, Department of Biosciences, COMSATS University Islamabad, Pakistan.
- Department of Endocrinology, Diabetes, and Metabolic Diseases, University Children's Hospital, University Medical Centre Ljubljana, Bohoriceva ulica 20, Ljubljana, Slovenia.
- Faculty of Medicine, University of Ljubljana, Vrazov trg 2, Ljubljana, Slovenia.
- Chemical Pathology, Chughtai Institute of Pathology, Lahore, Pakistan.
ORCID-Profile: Madeeha Khan, Quratul Ain, Jaka Sikonja, Hijab Batool, Muhammad Qasim Hayat, Mohammad Iqbal Khan, Urh Groselj, Fouzia Sadiq
Zitieren
APA
Khan, M., Ain, Q., Sikonja, J., Batool, H., Hayat, M. Q., Khan, M. I., Groselj, U., & Sadiq, F. (2025). Prevalence of Familial Hypercholesterolemia in Pakistan: A Pooled Analysis of 1.5 Million Individuals and Comparison with Other Countries of the Region. Global Heart. https://doi.org/10.5334/gh.1413
Vancouver
Khan M, Ain Q, Sikonja J, Batool H, Hayat MQ, Khan MI, et al. Prevalence of Familial Hypercholesterolemia in Pakistan: A Pooled Analysis of 1.5 Million Individuals and Comparison with Other Countries of the Region. Global Heart. 2025. doi:10.5334/gh.1413
BibTeX
@article{Khan2025,
author = {Khan, Madeeha and Ain, Quratul and Sikonja, Jaka and Batool, Hijab and Hayat, Muhammad Qasim and Khan, Mohammad Iqbal and Groselj, Urh and Sadiq, Fouzia},
title = {Prevalence of Familial Hypercholesterolemia in Pakistan: A Pooled Analysis of 1.5 Million Individuals and Comparison with Other Countries of the Region},
journal = {Global Heart},
year = {2025},
doi = {10.5334/gh.1413}
}
EUVIMED